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A B S T R A C T 
 
 
 
Introduction:  From September 2005 to February 2007 the Australian Government funded the Point of Care Testing (PoCT) in General 
Practice Trial, a multi-centre, cluster randomised controlled trial to determine the safety, clinical effectiveness, cost-effectiveness and satisfaction 
of PoCT in General Practice. In total, 53 practices (23 control and 30 intervention) based in urban, rural or remote locations across three states 
(South Australia [SA], New South Wales [NSW] and Victoria [VIC]) participated in the Trial. Control practices had pathology testing performed 
by their local laboratory, while intervention practices conducted pathology testing by PoCT. In total, 4968 patients (1958 control and 
3010 intervention) participated in the Trial. The point-of-care (PoC) tests performed by intervention practices were: haemoglobin A1c (HbA1c) 
and urine albumin:creatinine ratio (ACR) on patients with diabetes, total cholesterol, triglyceride and high density lipoprotein (HDL) cholesterol 
on patients with hyperlipidaemia, and international normalised ratio (INR) on patients on anticoagulant therapy. Three PoCT devices measured 
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these tests: the Siemens DCA 2000 (Siemens HealthCare Diagnostics, Melbourne, VIC, Australia) for HbA1c and urine ACR; Point of Care 
Diagnostics Cholestech LDX analyser (Point of Care Diagnostics; Sydney, NSW, Australia) for lipids; and the Roche CoaguChek S (Roche 
Diagnostics; Sydney, NSW, Australia) for INR. Point-of-care testing in the General Practice Trial was underpinned by a quality management 
framework which included an on-going training and competency program for PoCT device operators. This article describes the design, 
implementation and results of the training and competency program.  
Methods:  An education and training resource package was developed for the Trial consisting of a training manual, a set of  
A3 laminated posters and a CD ROM. Five initial training workshops were held for intervention practices from each geographic region between 
August and October 2005 at three centres – Adelaide (SA), Bendigo (VIC) and Dubbo (NSW). These workshops combined theoretical training in 
the principles and practice of PoCT with ‘hands on’ practical training delivered in interactive small group sessions. At the completion of training, 
practice staff undertook a written and practical competency assessment and received a certificate of competency as a qualified device operator. 
Following each initial training workshop, practice staff completed a short satisfaction survey. Five refresher training workshops covering all 
geographic regions were delivered during late August 2006, coinciding with the 12 month point of the live phase of the Trial. At the completion 
of the Trial in February 2007, device operators completed a further questionnaire. 
Results:  Sixty device operators from 31 practices completed training and competency assessment as part of the Initial Training Workshop series. 
A further 20 device operators from 12 of the practices were trained in the 12 month period after the initial workshops; 19 of these staff were 
from rural or remote practices. In total 80 device operators comprising 74 practice staff and six GPs from 31 practices were trained and received 
competency certificates as part of Trial. In all, 19 device operators left the Trial either through personal resignation from an existing practice or 
because their practice withdrew from the Trial; the majority (84%) were from rural and remote practices. A total of 42 device operators from 
25 practices attended refresher training in the second half of 2006. Results from the satisfaction questionnaire completed by device operators 
following the initial training workshops showed there was unanimous agreement that the posters were useful for the conduct of daily PoCT and 
practical training in small groups was satisfactory as a training method. The quality and appropriateness of the PoCT training resources and the 
workshop overall was rated as either good or excellent by all respondents (100% and 78%, respectively). The responses by device operators to 
the post-Trial satisfaction questionnaire found a high level of satisfaction with PoCT across all geographic regions. Device operators from remote 
practices had the highest satisfaction levels for quality of training, usefulness of the training manual, ease of use of devices, confidence in the 
accuracy of PoCT results and preference for PoCT over laboratory testing. The usefulness of the posters for conducting PoCT achieved the 
highest satisfaction rating among operators from all three geographic regions. However the highest staff turnover rates and the highest number of 
requests for training of additional staff were from rural and remote practices. 
Conclusion:  The methods established for the implementation and delivery of training and competency assessment for the PoCT in General 
Practice Trial were appropriate and effective. Results of the evaluation showed rural and remote practices have a greater need for training and 
support compared to their urban counterparts and may require more flexible training options to cater for much higher rates of staff turnover. 
 
Key words:  Australia, general practice, point-of-care testing, satisfaction, training and competency. 
 
 
 
 
Introduction 
 
Point-of-care testing (PoCT) is defined as a pathology test 
performed on-site by or on behalf the treating doctor at the time of 
patient consultation, allowing the test result to be used to make an 
immediate decision about patient treatment1. Technological 
advances in the manufacture and design of PoCT devices has 
resulted in the global uptake of PoCT, currently increasing at a rate 
of 12% per annum2. The scope and application of PoCT is now 
expanding rapidly from the traditional hospital base to community-
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based primary care settings where the care of patients, particularly 
with chronic diseases, is now often focussed1.  
 
In Australia, PoCT for diabetes management is now firmly 
established in the Indigenous health sector through the national 
Quality Assurance for Aboriginal and Torres Strait Islander Medical 
Services (QAAMS) Program and it has proven robust, safe and 
clinically and culturally effective3-6. There is growing interest in 
PoCT in the Australian general practice setting and a review of the 
role and value of PoCT in this setting highlighted that rural and 
remote practices could be the main beneficiaries of PoCT7. 
However the review concluded that further work was needed to 
determine the clinical and economic benefits of PoCT in general 
practice. As a result, the Australian Government recently funded 
the PoCT in General Practice Trial, one of the largest and most 
comprehensive studies of PoCT ever conducted in this primary care 
setting8. 
 
The PoCT in General Practice Trial was a multi-centre, cluster 
randomised controlled trial to determine the safety, clinical 
effectiveness, cost-effectiveness and satisfaction of PoCT in general 
practice. Three lead organisations were contracted by the 
Australian Government to deliver the Trial, working 
collaboratively from an Adelaide base. They were the Discipline of 
General Practice from the University of Adelaide (who were 
responsible for overall Trial management and evaluation), the 
Community Point-of-Care Services (CPS) unit at Flinders 
University and the RCPA Quality Assurance Programs (QAP) Pty 
Ltd. 
 
 
The Trial ran for 18 months in the period 2005–2007. In total, 53 
practices based in urban, rural or remote locations across three 
states (South Australia, New South Wales and Victoria) participated 
in Trial. In all, 23 practices were randomised to the control group, 
which had pathology testing performed by their local laboratory; 
and 30 practices were randomised to the intervention group, which 
conducted pathology testing by PoCT. A total of 4968 patients 
(1958 control and 3010 intervention) participated in the Trial, all 
of whom had either diabetes, hyperlipidaemia and/or were taking 
anticoagulation therapy (warfarin). Full details on the Trial 
methodology, rationale, recruitment and baseline patient 
characteristics have been reported elsewhere8.  
 
The following point-of-care (PoC) tests were performed by 
intervention practices: haemoglobin A1c (HbA1c) and urine 
albumin:creatinine ratio (ACR) on patients with diabetes; total 
cholesterol, triglyceride and high density lipoprotein (HDL) 
cholesterol on patients with hyperlipidaemia; and international 
normalised ratio (INR) on patients on warfarin therapy. Three 
PoCT devices were used to measure these tests; the DCA 2000 
(Siemens HealthCare Diagnostics; Melbourne, VIC, Australia 
[formerly Bayer Australia]) for HbA1c and urine ACR; the 
Cholestech LDX analyser (Point of Care Diagnostics; Sydney, 
NSW, Australia) for total and HDL cholesterol and triglyceride; 
and the CoaguChek S (Roche Diagnostics; Sydney, NSW, Australia) 
for INR.  
 
Point-of-care testing at the intervention practices was underpinned 
by a quality management framework consisting of a training and 
competency program for device operators and the routine conduct 
of internal quality control and external quality assurance testing 
procedures (standard laboratory practices for monitoring analytical 
quality that were adapted for use in a general practice setting). 
Training for device operators is a crucial component of PoCT 
because device operators should have a sound knowledge and 
understanding of basic analytical concepts and the technical skill set 
required to perform PoCT to an analytical standard that is 
equivalent to a laboratory and safe for patient care. Point-of-care 
testing training and competency and the quality control program for 
the Trial were delivered by the PoCT Device Group, a consortium 
comprising scientists from the Flinders CPS unit working with 
industry partners from Bayer Australia, Point of Care Diagnostics 
and Roche Diagnostics. The external quality assurance program was 
delivered by the RCPA QAP group.  
 
This article describes the design and implementation of the training 
and competency program for device operators from intervention 
practices and assesses the effectiveness of the training program as 
judged by these operators.  
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Methods 
 
Ethics approval  
 
The PoCT in General Practice Trial was approved by five relevant 
independent Australian Human Research Ethics Committees. The 
Trial is registered with the Australian Clinical Trial Registry, 
Number 12612605000272695. 
 
Design of point-of-care testing training resource 
package 
 
An education and training resource package was developed for the 
Trial consisting of a training manual, a set of A3 laminated posters 
and a CD ROM. This resource package was written by the PoCT 
Device Manager (MS), with input from scientists from the PoCT 
Device Group and the RCPA QAP.  
 
The 162 page colour training manual contained both an 
introduction section and a test-specific section. The introduction 
covered the theory of PoCT and discussed the importance of quality 
management of PoCT devices, in particular the principles behind 
internal quality control and external quality assurance testing.  
 
The test-specific section covered the practical side of performing 
each of the PoC tests measured in the trial (HbA1c, urine ACR, 
total cholesterol, triglyceride, HDL cholesterol and INR), and 
described each test systematically under the following common 
headings: 
 
• the clinical use of the PoC test  
• a description of the PoCT device used to measure the test 
• a description of the PoCT method 
• how to perform the PoC test on a patient sample 
• how to test a quality control sample  
• how to test a quality assurance sample 
• how to perform basic maintenance procedures on the 
PoCT device. 
 
The manual also contained an appendix which provided information 
on topics including: 
• selected papers on the clinical use of each of the PoC tests 
• selected papers on how the PoCT method compared with 
the laboratory method for each test 
• specifications of the PoCT devices used in the Trial 
• common error messages for each PoCT device. 
 
A spiral bound set of 12 laminated A3 posters was also prepared for 
the Trial. The posters were designed to provide device operators 
with a user-friendly, step-by-step guide on how to perform a 
patient test, a quality control test and a quality assurance test for 
each PoC test. An example of the posters is shown (Fig1). The 
poster concept had previously proven very popular among 
Aboriginal health professionals trained as device operators for the 
QAAMS PoCT program for diabetes management in Aboriginal 
medical services3.  
 
The CD ROM contained an electronic copy of the training manual 
and poster set and associated spreadsheets. 
 
Point-of-care testing training workshops 
 
Five Initial Training Workshops were held for intervention 
practices from each geographic region between August and October 
2005 at three centres – Adelaide, South Australia (to cater mainly 
for urban practices), Bendigo, Victoria (for rural practices) and 
Dubbo, New South Wales (for remote practices).  
 
 
These workshops were each of two-day’s duration. They combined 
theoretical training in the principles and practice of PoCT, the tests 
and devices used and quality management procedures with ‘hands 
on’ practical training delivered in interactive small group sessions, 
with one scientist from the PoCT Device and/or RCPA QAP 
groups working with a maximum of three general practice staff. 
The training workshops also included sessions on PoCT 
accreditation and Trial protocol implementation provided by the 
Trial management and evaluation team. 
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Figure 1:  Example of a poster showing how to conduct point-of-care testing for INR on a patient sample (with permission of 
the Australian Government Department of Health and Ageing). 
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At the completion of training, practice staff were required to 
correctly answer a set of written competency questions related to 
each test and to perform a PoC test in the presence of a scientist. 
The written questions related to the clinical utility of tests and 
issues of technical or procedural nature covered in the theory 
section of training. The PoC test performed by the operator as part 
of initial competency assessment was either a quality control or 
quality assurance sample both of which had a set target value and an 
acceptable limit of performance around that target. Device 
operators were required to obtain a value for the sample tested that 
was within the acceptable limits to pass their practical competency. 
On successful completion of this written and practical assessment a 
competency certificate was presented to each practice staff 
member.  
 
From January to August 2006, further training sessions were held 
for intervention practices that required new practice staff to be 
trained. These were generally conducted as ’one-on-one’ sessions 
between the new operator and a CPS scientist and were often held 
on-site at the practice concerned. 
 
Five refresher training workshops covering all geographic regions 
were delivered during late August 2006, coinciding with the 
12 month point of the live phase of the Trial, as a commitment to 
continuing education and training for device operators. Refresher 
training workshops included an overview of the Trial thus far from 
the PoCT device, trial management and RCPA QAP groups and a 
feedback session for device operators to discuss issues related to the 
use of the PoCT devices, quality management and trial management 
procedures. 
 
Only device operators who had undergone full training and 
received a competency certificate were able to conduct routine 
PoCT during the Trial. A competency register was maintained by 
the PoCT device group throughout the Trial.  
 
 
 
 
Assessment of point-of-care testing training 
methods  
 
At the completion of each initial training workshop, practice staff 
completed a satisfaction survey from the PoCT device group 
designed to assess the general appropriateness of the methods 
employed and the overall effectiveness of PoCT training provided 
by the device group. The survey contained six questions, with 
respondents rating their level of satisfaction with each question 
according to a Likert scale9.  
 
At the completion of the Trial in February 2007, device operators 
completed a further questionnaire devised by the Trial evaluation 
team (from the Trial management group) in which they were asked 
to indicate how strongly they agreed/disagreed with eight 
statements concerning their satisfaction with aspects of PoCT using 
a visual analogue scale (VAS). A VAS is a horizontal line, 10 cm in 
length, with the left end labelled as ‘strongly disagree’ and the right 
end labelled as ‘strongly agree’. Participants mark on the line the 
point they feel represents their level of satisfaction and the distance 
from the left end of the line to the mark is measured. A larger value 
indicates a higher level of agreement with the statement. The 
median score (and inter-quartile range) was calculated for each 
statement using Statistical Program for Social Sciences v 13.0 (SPSS 
Inc; Chicago, IL, USA). Scores were split by geographic region to 
ascertain whether there was any difference in satisfaction levels with 
PoCT between urban, rural and remote practices.  
 
Results 
 
Practice staff trained as point-of-care testing device 
operators 
 
At the conclusion of the initial training workshop series 60 device 
operators from 31 practices completed training and received 
competency certificates, having passed both written and practical 
assessments.  
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From January to August 2006, a number of further training 
requests from practices were received due to either: (i) new 
nursing staff needing to be trained because their previous device 
operator had left the practice; or (ii) the practice requested training 
for further nursing staff in addition to their existing operators. In 
total 20 staff (1 urban, 6 rural and 13 remote) from 12 practices 
(1 urban, 4 rural and 7 remote) underwent training and 
competency certification during this period.  
 
Thus, in total, 80 device operators comprising 74 practice staff and 
six GPs from 31 practices were trained and received competency 
certificates as part of Trial. All 6 GPs who completed training as 
device operators were from rural (n = 2) and remote (4) locations. 
A summary of these practices and operators, split by geographic 
region, is provided (Table 1). 
 
In total, 19 device operators (3 urban, 6 rural and 10 remote) from 
11 practices (3 urban, 2 rural and 6 remote) left during the life of 
the Trial. Of these, 8 device operators (3 urban, 2 rural and 
3 remote) from 6 practices (3 urban, 1 rural and 2 remote) resigned 
for personal reasons. The remaining 11 device operators (4 rural 
and 7 remote, including one GP) left the Trial because their 
practice withdrew from the Trial.  
 
At the completion of the Trial, 61 device operators were still 
actively conducting PoCT at their practice. Of these active 
operators, 42 (69%) attended refresher training workshops held 
during the second half of 2006 (Table 2). 
 
Satisfaction questionnaires and general feedback 
from point-of-care testing device operators 
 
Initial training:  In response to the question ‘How would you 
describe the level of instruction on the theory of PoCT?’ 
56/57 respondents (95%) stated the level of instruction was 
appropriate. For the questions ‘Do you feel the posters will be 
useful for you on a day to day basis?’ and ‘Was working in small 
groups with a supporting scientist for practical instructions 
satisfactory as a training method?’, there was unanimous agreement 
among the 60 respondents that the posters were useful and the 
mode of practical training was satisfactory. The quality and 
appropriateness of the PoCT training resources was rated as either 
good or excellent by all 60 respondents (8  and 52, respectively). 
Figure 2 shows the responses of device operators to the questions 
‘How would you rate the support given to you during training by 
the scientific team?’ and ‘How would you rate the PoCT device 
training workshop overall?’ The response rate to these questions 
was 85% and 78%, respectively. 
 
Refresher training:  From the feedback sessions conducted as 
part of refresher training, PoCT operators were in general 
agreement that: 
 
• the poster set provided for practices remained useful, its 
size and clarity was good 
• PoCT devices had generally proven robust during the 
Trial 
• patients were generally satisfied with the PoC testing 
process and they felt a greater sense of ownership of their 
pathology results. 
 
End-of-trial satisfaction survey:  The responses by device 
operators to the Trial evaluation team’s post-Trial satisfaction 
questionnaire are displayed (Table 3). In total, 90% (55/61) of the 
active operators at the end of the Trial completed the 
questionnaire. Overall, a high level of satisfaction with PoCT was 
reported by operators across all geographic regions. Device 
operators from remote practices had the highest satisfaction levels 
for quality of training, usefulness of the training manual, ease of use 
of devices, confidence in the accuracy of PoCT results and 
preference for PoCT over laboratory testing. Rural device 
operators showed lowest levels of satisfaction for quality of 
training, competency in using the devices and confidence in the 
accuracy of PoCT results. Urban device operators recorded the 
highest levels of satisfaction for usefulness of posters and 
competency in using the devices, but a lower degree of satisfaction 
with ease of device use and preference for PoCT over laboratory 
testing. The usefulness of the posters for conducting PoCT achieved 
the highest satisfaction rating among operators from all three 
geographic regions.  
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Table 1:  Practices and device operator training during the Trial by geographic region 
 
Geographic 
location 
Initial training workshop 
August–October 2005 
Additional training 
January–August 2006 
Total device operators trained 
over Trial 
Practices Device operators Existing 
practices 
Device operators Practices Device operators 
Practice 
Staff 
GP Practice 
staff 
GP Practice 
staff 
GP 
Urban 8 18 0 1 1 0 8 19 0 
Rural 9 20 2 4 6 0 9 26 2 
Remote 14 17 3 7 12 1 14 29 4 
Total 31 55 5 12 19 1 31 74 6 
 
 
 
Table 2:  Practices and device operators undertaking refresher training by geographic region 
 
Geographic location Refresher training 
August–November 2006 
Practices Device operators 
Practice staff GPs 
Urban 8 12 0 
Rural 7 15 1 
Remote 10 14 0 
Total 25 41 1 
 
 
 
 
 
Discussion 
 
A quality framework that ensures continuous training and on-going 
surveillance of analytical quality is a critical and fundamental 
element for underpinning a successful and sustainable PoCT model, 
particularly in a community setting10-16. The methods for education, 
training and competency assessment developed by the PoCT Device 
Group for use in this Trial were consistent with those: (i) used 
successfully in PoCT programs for chronic disease management in 
the Aboriginal community setting in Australia, notably the QAAMS 
and Point-of-Care Testing in Aboriginal Hands Programs3-6,17; and 
(ii) recommended for PoCT by the International Organisation for 
Standardization (ISO) and the Clinical and Laboratory Standards 
Institute (CLSI; formerly the NCCLS)18-19.  
 
The Initial Training Workshop series for the PoCT in General 
Practice Trial featured the novel use of laminated poster series for 
day-to-day conduct of PoCT and interactive small group sessions 
for practical training managed by medical scientists and supported 
by industry. The use of primary trainers with strong medical 
science backgrounds, experience in delivering PoCT training 
programs and having expertise in tailoring training methods to 
targeted audiences of different health professional groups 
contributed significantly to the success of the training program. Of 
particular importance in this regard was the ability to translate 
complex laboratory terms such as accuracy, precision, quality 
control and quality assurance into readily understandable concepts 
for non-laboratory trained device operators, while at the same time 
adhering to the requirements of international (NCCLS/ISO) 
guidelines for the conduct of PoCT. 
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Figure 2:  Point-of-care testing device operator response to selected questions at the completion of initial training workshop 
series. 
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Table 3:  Point-of-care testing device operator responses to end-of-trial satisfaction questionnaire by geographic location 
 
Characteristic Location 
median (IQ range) 
Urban 
n = 13 
Rural 
n = 19 
Remote 
n = 23 
Quality of training was satisfactory  8.5 (7.7-9.5) 8.2 (6.4-9.0) 8.6 (7.4-9.3) 
Usefulness of PoCT Training Manual for PoCT devices 8.2 (6.8-9.6) 8.5 (7.2-9.5) 8.6 (7.0-9.5) 
Usefulness of posters for PoCT devices 9.6 (8.6-9.8) 9.4 (6.1-9.8) 9.3 (8.3-9.8) 
I am competent in use of PoCT devices 9.4 (8.1-9.6) 8.2 (7.2-9.7) 9.0 (7.7-9.6) 
PoCT devices were easy to use 8.3 (7.0-9.5) 8.5 (7.2-9.7) 9.1 (8.3-9.5) 
PoCT devices were easy to maintain 9.0 (8.8-9.4) 9.1 (7.9-9.8) 8.9 (8.2-9.2) 
Confident in accuracy of PoCT results 8.4 (7.2-8.5) 7.3 (5.8-8.3) 8.5 (7.7-9.2) 
Prefer PoCT to conventional pathology testing 7.9 (6.2-9.2) 8.5 (7.3-9.2) 8.8 (7.4-9.6) 
                                    PoCT, Point-of-care testing. 
 
 
Responses from device operators from all geographic regions to 
satisfaction surveys conducted by the PoCT Device Group (after the 
initial training workshop series) and by the Trial evaluation team (at 
the conclusion of the Trial) indicated that there was widespread 
acceptance of training methods and their effectiveness. The 
acceptance of the poster sets as a user-friendly and practical training 
resource was confirmed by the very high satisfaction levels reported 
among device operators.  
 
Point-of-care testing has particular application for rural and 
especially remote health practices where access to laboratory 
services may be limited, turnaround time for receipt of results may 
be delayed and rate of patient return for follow up of laboratory 
results may be low20. The positive responses from remote operators 
relating to ease of use of PoCT devices, confidence in the accuracy 
of results and preference for PoCT over laboratory testing augurs 
well for the acceptance of PoCT in this geographic sector. However 
the challenges faced by the rural and remote health services, 
particularly in relation to sustaining both workforce capacity and 
the ability to conduct PoCT are considerable. High rates of staff 
turnover are a constant problem for rural and remote services. In 
this study, 16 (84%) of the 19 device operators who left the study 
were from rural (6) or remote (10) practices; 5 (63%) of the 
8 device operators who resigned were from these geographic 
regions. Four (80%) of the 5 practice withdrawals were from rural 
and remote areas. Maintaining and delivering staff training and the 
capacity to conduct quality-assessed PoCT can also be strained in 
the face of high staff turnover. It is noteworthy that 11 (92%) of the 
12 practices that requested additional training in the  
9–12 month period post the initial training workshop series were 
from rural (4) or remote (7) practices. Further 19 (95%) of the 
20 new staff trained were from rural (6) or remote (13) practices. 
These observations highlight that not only do rural and remote 
practices have a greater need for training and support compared to 
their urban counterparts but also require more flexible training 
options to cater for much higher rates of staff turnover. Regular 
face-to-face training by a primary training team may be impractical 
and too expensive for a remote general practice experiencing high 
staff turnover. Access to electronic training resources such as DVD 
or web-based training through web-streamed video presentations 
(such as those being currently used in the QAAMS Program5-6) may 
provide alternative training options for this geographic niche. 
 
During the live phase of the Trial, on-going device operator 
competency was assessed by the routine conduct of quality testing. 
The results of this testing have been reported elsewhere and 
indicate that device operators conducted PoCT to a generally 
acceptable standard21. 
 
In conclusion, the methods established for the implementation and 
delivery of training and competency assessment were appropriate 
for the PoCT in General Practice Trial. However, findings from 
this study have emphasised the greater need for training and support 
for PoCT services in rural and remote practices and the necessity 
for more flexible training options to address much higher rates of 
staff turnover. 
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